TD Private Client Wealth LLC Has $8.80 Million Stake in CVS Health Corporation $CVS

TD Private Client Wealth LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 17.1% in the third quarter, Holdings Channel reports. The institutional investor owned 116,729 shares of the pharmacy operator’s stock after purchasing an additional 17,055 shares during the period. TD Private Client Wealth LLC’s holdings in CVS Health were worth $8,800,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the company. First United Bank & Trust raised its holdings in CVS Health by 6.2% in the 3rd quarter. First United Bank & Trust now owns 10,492 shares of the pharmacy operator’s stock valued at $791,000 after acquiring an additional 612 shares in the last quarter. GRIMES & Co WEALTH MANAGEMENT LLC increased its position in shares of CVS Health by 79.7% during the third quarter. GRIMES & Co WEALTH MANAGEMENT LLC now owns 17,136 shares of the pharmacy operator’s stock valued at $1,292,000 after purchasing an additional 7,599 shares during the period. Quent Capital LLC bought a new stake in shares of CVS Health during the third quarter valued at approximately $155,000. Polaris Capital Management LLC lifted its position in CVS Health by 23.7% in the third quarter. Polaris Capital Management LLC now owns 602,600 shares of the pharmacy operator’s stock worth $45,430,000 after purchasing an additional 115,500 shares during the period. Finally, St. Johns Investment Management Company LLC boosted its stake in CVS Health by 17.3% during the third quarter. St. Johns Investment Management Company LLC now owns 10,161 shares of the pharmacy operator’s stock worth $766,000 after buying an additional 1,496 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on CVS shares. Jefferies Financial Group increased their price objective on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Piper Sandler reissued an “overweight” rating and issued a $101.00 target price (up previously from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Leerink Partners raised their price target on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Wolfe Research upped their price objective on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research report on Wednesday, December 10th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $94.86.

CVS Health Stock Performance

NYSE CVS opened at $80.36 on Tuesday. CVS Health Corporation has a 1-year low of $49.52 and a 1-year high of $85.15. The company has a 50 day moving average of $78.73 and a 200-day moving average of $74.02. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The firm has a market cap of $102.02 billion, a price-to-earnings ratio of 211.49, a PEG ratio of 0.74 and a beta of 0.48.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the business earned $1.09 EPS. CVS Health’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd. CVS Health’s payout ratio is currently 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.